27 NOV 2018

UDG HEALTHCARE PLC
PRELIMINARY ANNOUNCEMENT OF RESULTS 
YEAR ENDED 30 SEPTEMBER 2018

Solid performance drives 22% full-year constant currency EPS growth

27 November 2018: UDG Healthcare plc (“UDG Healthcare” or “Group”), a leading international healthcare services provider, announces its preliminary results for the year ended 30 September 2018, in which the Group continued to deliver strong EPS growth.

Download Results



Financial Results

 

IFRS

based 

$'m

Adjustments1

$'m

Adjusted

$'m

 

Increase

on 2017

%

Constant

currency

Increase

on 2017

%

Continuing operations     
Revenue 1,315.2 - 1,315.2   8 5
Net revenue2  1,129.7 - 1,129.7 10 6
           
Operating profit 5.5 142.0 147.5 14 12
Profit before tax 8.4 130.4 138.8 17 15
Diluted earnings per share (EPS) (cent) 1.52 44.42 45.94 24 22
Dividend per share (cent) 16.00 - 16.00 20 20
           

 

  2018 2017
Net debt ($’m) 60.8 53.3
Net debt/annualised EBITDA (times) 0.34 0.32



1 Adjusted operating profit, profit before tax and diluted EPS are stated before the amortisation of acquired intangible assets ($31.0m, pre-tax), transaction costs ($2.4m, pre-tax) and exceptional charges (operating charge $108.6m, pre-tax $97.1m and post-tax $85.8m) relating to the disposal and impairment of Aquilant ($90.7m charge), the Group’s restructure of internal operating structures ($18.0m charge), deferred contingent consideration adjustments ($11.6m gain), net tax effect of these items ($1.5m gain), and an exceptional credit to deferred tax liabilities ($9.7m gain). See note 7.  

2 Net revenue represents gross revenue adjusted for revenue associated with pass-through costs, for which the Group does not earn a margin.

 RESULTS VIDEO

 

 

Download Results

View Webcast

Download FY18 Results Presentation & Booklet

Download Results Infographic